AUG 17, 2016 5:48 PM PDT

How Can We Improve Vaccines Based on Natural Immune Trends?

WRITTEN BY: Kara Marker
Some cells in the immune system are for constantly pumping out antibodies during an infection, while others are saved for later should the same pathogen strike again. In a new study from the Emory Vaccine Center and Stanford’s Department of Pathology, scientists investigated how the immune system differentiates between the two types of cells, in order to adapt a similar process to the development of more effective vaccines. 
Presence of lymphocytes as an infection progresses
Plasmablasts are responsible for immediate antibody production when a pathogen invades the body. Activated B cells, the immune cells that precede memory B cells, don’t secrete antibodies spontaneously like plasmablasts do. However, they can be stimulated to secrete different antibodies according to the content of their DNA. In their recent study published in the journal Nature Immunology, researchers tracked the path of B cells during an immune response by following their DNA patterns.

The team of scientists studied the activity of activated B cells after influenza vaccination, after influenza infection, and during Ebola virus infection. Why Ebola? “Ebola virus infection represents a situation when the patients’ bodies were encountering something they’ve never seen before,” said lead author Ali Ellebedy, PhD. “In contrast, during both influenza vaccination and infection, the immune system generally is relying on recall.”

One week after study participants were immunized for influenza, both flu-specific plasmablasts and flu-specific activated B cells were detected in their blood. However, two weeks after the immunization, the plasmablasts had completely disappeared from the blood, while the activated B cell cells were still proliferating. 

Months after the immunization, activated B cells had completed the transition into resting memory B cells, giving scientists the full picture of how memory cells are produced.

Additionally, they saw a similar trend in Ebola patients with a progressing infection: as the plasmablast count decreased in the blood, the activated B cell count increased. 

With more insight into how antibody-producing cells diminish over time, researchers might make some changes to the way vaccines are created.

“It is still worthwhile to encourage the immune system to make a greater quantity of antibodies, even if their quality does not rise appreciably, and the value of vaccination may be greater when the flu vaccine strains are not identical to those used in previous seasons’ vaccines,” Ellebedy said.
 


Source: Emory Health Sciences
Image: Blood Journal
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 07, 2020
Neuroscience
FEB 07, 2020
Eating Fruits and Vegetables May Lower Alzheimer's Risk
New research has found that flavonols, a large class of compounds present in many fruits and vegetables, may be linked t ...
FEB 21, 2020
Drug Discovery & Development
FEB 21, 2020
New Antibiotics Found Using AI Technology
Using AI, researchers at MIT have found a powerful new antibiotic capable of killing some of the most dangerous drug-res ...
MAR 20, 2020
Health & Medicine
MAR 20, 2020
Why Does COVID-19 Kill So Many Older People?
Since early statistics began to emerge from China, it seemed that COVID-19 tended to affect older people more than young ...
APR 21, 2020
Health & Medicine
APR 21, 2020
How to Read COVID-19 News (Without Going Crazy)
  It can feel like COVID-19 news is consuming the country, and taking all the toilet paper and N95-masks with it. N ...
MAY 05, 2020
Immunology
MAY 05, 2020
Winter the Llama: An Unlikely Hero in the Fight Against COVID-19
A new hero in the fight against COVID-19 has emerged: 4-year-old Winter, a llama that currently resides in the Belgian c ...
MAY 14, 2020
Immunology
MAY 14, 2020
Antibody-laden Nanoparticles to Help COVID Patients Breathe Easy
Antibodies are a powerful countermeasure against COVID-19. Not only can they relieve symptoms in patients experiencing s ...
Loading Comments...